Bliley TI
[Memorandum Regarding FDA Regulation of Low-Yield Cigarettes as a Drug]
Abstract
Transmits information from news conference by "Coalition on Smoking or Health" on two petitions filed with Food and Drug Administration (FDA): "one to have RJR's [R.J. Reynolds] announced new cigarette regarded as a drug for regulatory purposes, and the other to treat current low-yield cigarette brands the same way." States official Tobacco Institute response "after consultation with counsel...that there is a seeming inconsistency in the Coalition position given the historic affirmations by both Congress and FDA that cigarettes are outside the agency's statutory authority" (attachments missing).
Fields
- Company
- Tobacco Institute
- Named Organization
- Coalition on Smoking or Health
- Congress
- Counsel
- FDA
- Food and Drug Administration
- R.J. Reynolds Tobacco Co.
- R.J. Reynolds Tobacco Co. (Cigarette manufacturer (Camel, Winston, Doral))Cigarette manufacturer (Camel, Winston, Doral)
- Keyword
- Low-yield cigarettes
- Author
- Chilcote, Samuel D., Jr. (TI President (1981-1997))Chilcote has knowledge of The Tobacco Institute's and the tobacco industry's participation in public fraud and disinformation relative to health hazards of tobacco use, in the manipulation of nicotine in tobacco products and in marketing of tobacco products to children.
- Recipient
- Members of the Executive Committee
Document Images
CONFIDENTIAL:
MINNESOTA TOBACCO LITIGATION
THE TOBACCO INSTITUTg
1875 [ STREET, NORTHWEST
SAMUEL D. CHILCOTE,
WASHINGTON. DC 20006
President
202/457-4800 • 800/424-9876
April 25, 1988
TO: Members of the Executive Committee
FR: Samuel D. Chilcote, Jr.t/-~_~C~._~~
At a moderately well attended news conference this morning,
the Coalition on Smoking OR Health announced its filing of
two petitions at the U.S. Food & Drug Administration -- one
to have RJR'S announced new cigarette regarded as a drug
for regulatory purposes, and the other to treat current
low-yield cigarette brands the same way.
The enclosed media material distributed by the Coalition
may be of specific interest to your legal counsel.
In response to media inquiries for our reaction,[after
consultation with counsel~our staff is stating t-hat we
have not had an opportunity to study the Coalition
documents, and that there is a seeming inconsistency in the
Coalition position given the historic affirmations by both
Congress and FDA that cigarettes are outside the agency's
statutory authority.
TIMN 0019990
